201 related articles for article (PubMed ID: 16968235)
1. Oral shedding of herpes simplex virus type 1 in immunocompetent persons.
Gilbert SC
J Oral Pathol Med; 2006 Oct; 35(9):548-53. PubMed ID: 16968235
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients.
da Silva LM; Guimarães AL; Victória JM; Gomes CC; Gomez RS
Oral Dis; 2005 Jan; 11(1):13-6. PubMed ID: 15641961
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis.
Boivin G; Goyette N; Sergerie Y; Keays S; Booth T
J Clin Virol; 2006 Dec; 37(4):248-51. PubMed ID: 17046320
[TBL] [Abstract][Full Text] [Related]
4. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
5. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
Kim HN; Meier A; Huang ML; Kuntz S; Selke S; Celum C; Corey L; Wald A
J Infect Dis; 2006 Aug; 194(4):420-7. PubMed ID: 16845624
[TBL] [Abstract][Full Text] [Related]
6. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
8. The impact of dental surgery on HSV-1 reactivation in the oral mucosa of seropositive patients.
Marques-Silva L; Castro WH; Gomez EL; Guimarães AL; Silva MS; Gomez RS
J Oral Maxillofac Surg; 2007 Nov; 65(11):2269-72. PubMed ID: 17954324
[TBL] [Abstract][Full Text] [Related]
9. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity.
Miller CS; Danaher RJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):43-50. PubMed ID: 17703961
[TBL] [Abstract][Full Text] [Related]
11. HSV shedding.
Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
Antiviral Res; 2004 Aug; 63 Suppl 1():S19-26. PubMed ID: 15450382
[TBL] [Abstract][Full Text] [Related]
12. Detection of herpes simplex virus type 1 shedding in the oral cavity by polymerase chain reaction and enzyme-linked immunosorbent assay at the prodromal stage of recrudescent herpes labialis.
Scott DA; Coulter WA; Biagioni PA; O'Neill HO; Lamey PJ
J Oral Pathol Med; 1997 Aug; 26(7):305-9. PubMed ID: 9250929
[TBL] [Abstract][Full Text] [Related]
13. Oral shedding of herpes simplex virus type 1: a review.
Scott DA; Coulter WA; Lamey PJ
J Oral Pathol Med; 1997 Nov; 26(10):441-7. PubMed ID: 9416573
[TBL] [Abstract][Full Text] [Related]
14. Viral Genetics Modulate Orolabial Herpes Simplex Virus Type 1 Shedding in Humans.
Ramchandani MS; Jing L; Russell RM; Tran T; Laing KJ; Magaret AS; Selke S; Cheng A; Huang ML; Xie H; Strachan E; Greninger AL; Roychoudhury P; Jerome KR; Wald A; Koelle DM
J Infect Dis; 2019 Mar; 219(7):1058-1066. PubMed ID: 30383234
[TBL] [Abstract][Full Text] [Related]
15. High frequency of detection of herpes simplex virus DNA in the oral cavity of patients with eczema herpeticum.
Yoshida M; Amatsu A
Dermatology; 2004; 209(2):101-3. PubMed ID: 15316162
[TBL] [Abstract][Full Text] [Related]
16. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.
de Bruyn G; Vargas-Cortez M; Warren T; Tyring SK; Fife KH; Lalezari J; Brady RC; Shahmanesh M; Kinghorn G; Beutner KR; Patel R; Drehobl MA; Horner P; Kurtz TO; McDermott S; Wald A; Corey L
Vaccine; 2006 Feb; 24(7):914-20. PubMed ID: 16213066
[TBL] [Abstract][Full Text] [Related]
18. Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?
Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
Antiviral Res; 2004 Aug; 63 Suppl 1():S3-9. PubMed ID: 15450380
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission.
Mertz GJ
J Infect Dis; 2008 Oct; 198(8):1098-100. PubMed ID: 18783317
[No Abstract] [Full Text] [Related]
20. An update on short-course intermittent and prevention therapies for herpes labialis.
Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
